Your browser doesn't support javascript.
loading
FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma.
Song, Meifang; Ma, Luyuan; Shen, Chuan; Liu, Wenpeng; Zhang, Pengfei; Bi, Ranran; Zhao, Caiyan.
Afiliación
  • Song M; Department of Infectious Diseases, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Ma L; Department of Infectious Diseases, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Shen C; Department of Infectious Diseases, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Liu W; Department of Hepatobiliary Surgery, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Zhang P; Department of Hepatobiliary Surgery, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Bi R; Department of Infectious Diseases, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Zhao C; Department of Infectious Diseases, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China. Electronic address: zhaocy2005@163.com.
Cell Signal ; 111: 110828, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37517671
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Signal Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Signal Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido